Effect of curcumin on JAK-STAT signaling pathway in hepatoma cell lines

Yaoxue Xuebao

Volumn 44, Issue 12, 2009, Pages 1434-1439

  Wang, Wei Zhang ^a   Zhang, Bi Yu ^b   Yuan, Jian ^a   Mao, Jian Wen ^a   Mei, Wen Jie ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Curcumin; Hepatoma cell; JAK STAT signaling pathway

Indexed keywords

CURCUMIN; JANUS KINASE; STAT1 PROTEIN; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; LIVER CELL CARCINOMA; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMA; CURCUMIN; HUMANS; JANUS KINASES; LIVER NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANTS, MEDICINAL; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 76249118370     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hatcher H, Planalp R, Cho J, et al. Curcumin: from ancient medicine to current clinical trials [J]. Cell Mol Life Sci, 2008, 65: 1631-1652.
2. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions [J]. Anticancer Res, 2001, 21: 2895-2900.
3. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer [J]. Clin Cancer Res, 2008, 14: 4491-4499.
4. Heim MH. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus [J]. J Recept Signal Transduct Res, 1999, 19: 75-120.
5. Akira S. Functional roles of STAT family proteins: lessons from knockout mice [J]. Stem Cells, 1999, 17: 138-146.
6. Durbin JE, Hackenmiller R, Simon MC, et al. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease [J]. Cell, 1996, 84: 443-450.
7. Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway [J]. Cell, 1996, 84: 431-442.
8. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention [J]. Clin Cancer Res, 2002, 8: 945-954.
9. Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias [J]. Oncogene, 2000, 19: 2496-2504.
10. Huang E, Cheng SH, Dressman H, et al. Gene expression predictors of breast cancer outcomes [J]. Lancet, 2003, 361: 1590-1596.
11. Thomas M, Finnegan CE, Rogers KM, et al. STAT1: a modulator of chemotherapy-induced apoptosis [J]. Cancer Res, 2004, 64: 8357-8364.
12. Roberts D, Schick J, Conway S, et al. Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells [J]. Br J Cancer, 2005, 92: 1149-1158.
13. Fryknas M, Dhar S, Oberg F, et al. STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines [J]. Int J Cancer, 2007, 120: 189-195.
14. Khodarev NN, Beckett M, Labay E, et al. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells [J]. Proc Natl Acad Sci USA, 2004, 101: 1714-1719.
15. Patterson SG, Wei S, Chen X, et al. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells [J]. Oncogene, 2006, 25: 6113-6122.
16. Kita K, Sugaya S, Zhai L, et al. Involvement of LEU13 in interferon-induced refractoriness of human RSa cells to cell killing by X rays [J]. Radiat Res, 2003, 160: 302-308.
17. Steiner E, Holzmann K, Pirker C, et al. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals [J]. J Cell Sci, 2006, 119: 459-469.
18. Malakhova OA, Yan M, Malakhov MP, et al. Protein ISGylation modulates the JAK-STAT signaling pathway [J]. Genes Dev, 2003, 17: 455-160.
19. Calvisi DF, Pascale RM, Feo F. Dissection of signal transduction pathways as a tool for the development of targeted therapies of hepatocellular carcinoma [J]. Rev Recent Clin Trials, 2007, 2: 217-236.
20. Wang WZ, Cheng J, Luo J, et al. Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis [J]. FEBS Lett, 2008, 582: 2689-2695.
21. [21 ] Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins [J]. Cancer Lett, 2008, 269: 199-225.
22. Rajasingh J, Raikwar HP, Muthian G, et al. Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia [J]. Biochem Biophys Res Commun, 2006, 340: 359-368.
23. Ihle JN, Witthuhn BA, Quelle FW, et al. Signaling by the cytokine receptor superfamily: JAKs and STATs [J]. Trends Biochem Sci, 1994, 19: 222-227.
24. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation [J]. Cell, 1995, 82: 241-250.
25. Blasius R, Reuter S, Henry E, et al. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells [J]. Biochem Pharmacol, 2006, 72: 1547-1554.